Rising demand for recreational cannabis :)NetworkNewsWire Announces Publication Featuring Challenges Facing Canada's Licensed Producers as Recreational Cannabis Market Looms Thursday, November 16, 2017, 8:30 AM ET NetworkNewsWire Announces Publication Featuring Challenges Facing Canada's Licensed Producers as Recreational Cannabis Market Looms NEW YORK, NY--(Marketwired - Nov 16, 2017) - NetworkNewsWire ("NNW"), a multifaceted financial news and publishing company, today announces the publication of an editorial featuring ABcann Global Corp. (OTCQB: ABCCF) (TSX VENTURE: ABCN), a globally licensed, cost efficient producer of premium quality organic standardized medicinal cannabis and one of the earliest licensed Canadian medical marijuana producers. The publication, titled, "Rising Demand for Cannabis Oils Pushes Canada's Producers into Overdrive," outlines the efforts the country's licensed producers are undertaking as they ratchet up cannabis production to meet anticipated demands when recreational marijuana becomes legal in mid-2018. To view the full publication, visit: https://www.networknewswire.com/rising-demand-cannabis-oils-pushes-canadas-producers-overdrive/ "ABcann Global (OTCQB: ABCCF) (TSX VENTURE: ABCN) is leveraging its position as a globally licensed, cost efficient producer of premium quality organic standardized medicinal cannabis to expand its product line to include cannabis oils. As one of Canada's first licensed cannabis producers, ABcann is significantly ahead of the curve when it comes to production capacities. The company's licensed and fully operational Vanluven Facility produces 1,000 kg annually. Construction on the company's Kimmett facility, an industry-leading, purpose-built, world class style facility, is under contract with another 65 acres under full Abcann ownership for future expansion plans. "ABcann's wholly owned ABcann Medicinals, Inc. subsidiary in August launched CBD-Med, one of Canada's highest legal CBD:THC (cannabidol: tetrahydrocannabinol) ratio products available on the market (https://nnw.fm/sYv7g), under Health Canada regulations. CBD-Med's high CBD content is a vital differentiating factor. Although the virtues of THC have been loudly sung, many patients exhibit adverse reactions... CBD is devoid of such side effects and, moreover, appears to mitigate the injurious effects of THC when taken in conjunction with it." About ABcann Global Corp. ABcann holds production and sales licenses from Health Canada. Its flagship facility in Napanee, Ontario contains proprietary plant-growing technology, centered on its specially designed, environmentally-controlled growing chambers. This approach results in the production of pharmaceutical-grade cannabis products. The company is expanding its cultivation capacity and pursuing partnership and product development opportunities domestically, as well as in select international markets, such as Germany, Australia and Israel. For more information, visit www.ABcannGlobal.com.